HCW Biologics Inc.
HCW Biologics Inc. (HCWB) Revenue
Annual & quarterly revenue history · segment & region breakdown
HCWB · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsHCW Biologics Inc. trailing twelve-month (TTM) revenue is $0.01B, a decrease of 97.89% year-over-year from $0.00B in FY2025.
Revenue trend
2025 – 2019 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.00B | -$0.00B | -97.89% |
| 2024-12-31 | $0.00B | -$0.00B | -9.68% |
| 2023-12-31 | $0.00B | -$0.00B | -57.72% |
| 2022-12-31 | $0.01B | +$0.01B | — |
| 2021-12-31 | $0.00B | -$0.00B | -100.00% |
| 2020-12-31 | $0.00B | +$0.00B | — |
| 2019-12-31 | $0.00B | — | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income HCW Biologics Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
HCW Biologics Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from HCW Biologics Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
HCWB revenue · 4 questionsHCWB's trailing twelve-month (TTM) revenue is $0.01B. That is a decrease of 97.89% year-over-year from $0.00B in FY2025.
▸ Source: FMP · HCW Biologics Inc. SEC filings · GAAP · HCW Biologics Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026